REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Clinical trial NCT02291809 · UNKNOWN
Trial details
- NCT number
- NCT02291809
- Sponsor
- Immune Response BioPharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2019-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.